DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Epzicom (Abacavir Sulfate / Lamivudine) - Current Clinical Trials


Epzicom Related Clinical Trials

Pharmacokinetic Study Of EPZICOM Tablet [Completed]

Comparison of Epzicom and Truvada for the Initial Once Daily HIV Treatment [Completed]

Pilot Study With Isentress (Raltegravir) and Epzicom (Abacavir/Lamivudine) in Treatment Naive HIV-Infected Subjects [Active, not recruiting]

Artery Elasticity After Switch From Epzicom to Truvada [Terminated]

Abacavir/Lamivudine Versus Emtricitabine/Tenofovir Both In Combination With Lopinavir/Ritonavir For The Treatment Of HIV [Completed]

A Simplification Study of Unboosted Reyataz With Epzicom (ASSURE) [Completed]

Safety and Efficacy Study of Switching From Epzicom to Truvada [Completed]

A Study in Underrepresented Patient Population or Regimen Tolerability: SUPPoRT [Completed]

A Randomised, Open-label Trial to Assess the Safety and Efficacy of Switching to Tenofovir-emtricitabine or Abacavir-lamivudine: The STEAL Study [Completed]

Comparing the Effectiveness Between Ritonavir Boosted Atazanavir and Efavirenz for the First HIV Treatment [Completed]

A Randomized, Prospective Study of the Efficacy, Safety and Tolerability of Two Doses of GW433908Ritonavir Given With Abacavir/Lamivudine Fixed Dose Combination [Completed]

ROCKET II - Randomized Open Label Switch for Cholesterol Elevation on Kivexa + Kaletra Evaluation Trial [Completed]

Clinical Trial of CNS-targeted HAART (CIT2) [Completed]

Nucleoside Switch Pilot for Virologically Controlled HIV Subjects With Decreasing CD4 Cells Who Have Received TDF-based ARV Therapy [Recruiting]

Antiretroviral Pregnancy Registry (APR)-Risk of Birth Defects [Recruiting]

Study of Options for Second-Line Effective Combination Therapy (SELECT) [Active, not recruiting]

Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 Infection [Completed]

Raltegravir + Lamivudine/Abacavir in HIV/Tuberculosis Co-Infected Patients [Recruiting]

A Pilot Study Of the Effects of Highly Active Antiretroviral Therapy on Kaposi's Sarcoma in Zimbabwe [Completed]

HIV Treatment and CVD Events [Completed]

KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 Weeks [Completed]

Fractures Stratified by HIV and Antiretroviral Therapy (ART) Status [Completed]

Once-Daily Drug Regimen for HIV-Infected Patients [Completed]

Pharmacokinetic (PK) Study of Twice Daily vs Once Daily Lamivudine (3TC) and Abacavir (ABC) as Part of Combination Antiretroviral Therapy (ART) in HIV Infected Children [Completed]

A Trial Comparing GSK1349572 50mg Plus Abacavir/Lamivudine Once Daily to Atripla (Also Called The SINGLE Trial) [Active, not recruiting]

New Tablet Containing Two FDA Approved Anti-HIV Drugs For Antiretroviral Therapy Experienced HIV-1 Infected Subjects [Completed]

A HIV Study Of A Fixed-Dose Combination Tablet In Antiretroviral Experienced Patients [Completed]

MARCH Vascular Endothelium Substudy [Active, not recruiting]

Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor (PI) and Two Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to a Fixed-dose Tablet Containing Emtricitabine/Rilpivirine/Tenofovir DF [Completed]

Second-line Treatment of HIV-1 With Ritonavir Boosted Atazanavir or Darunavir With an Optimized NRTI Backbone [Withdrawn]

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017